Master thesis is primarily focused on parallel trade with medicinal drugs within European Union. In regard to attractive offer for cooperation with strong supplier of mentioned goods was required to valorise realization possibility and potential of idea. Business plan estimates different variants or realization and progress, describes it in numbers and wide context. Object of thesis is absolutely real case of starting intermediary company in pharmaceutical field specifically in parallel "reexport" of pharmaceutical drugs and accessories between states of European Economic Area. In first two passages study remembers methodology of business plan and passes to bases of legislative frame related with. Subsequently are described market movements, thoroughly analysed its weak points and also strengths and opportunities. Everything is simultaneously reflected with object of our business plan to support reality of whole master thesis. After short marketing passage comes the largest part dealing with financial calculations. Considered are three variants of potential reality and in each of them are calculated costs, revenues, profit and cash flow for single months and whole year. Conclusion summarizes and evaluate project as whole. Considering infestation of input costs against its rentability and potential other opportunities of the pharmaceutical market. Evolution of European market mostly depends on legislation regulations of EU and single countries.
| Identifer | oai:union.ndltd.org:nusl.cz/oai:invenio.nusl.cz:162870 |
| Date | January 2011 |
| Creators | Šašek, Otakar |
| Contributors | Tyll, Ladislav, Strouhal, Jiří |
| Publisher | Vysoká škola ekonomická v Praze |
| Source Sets | Czech ETDs |
| Language | Czech |
| Detected Language | English |
| Type | info:eu-repo/semantics/masterThesis |
| Rights | info:eu-repo/semantics/restrictedAccess |
Page generated in 0.002 seconds